MedTrace Logo

HD-tDCS for Pain Reduction in Post-Stroke Pain: a Randomized Crossover Trial

NCT06740591 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-12-18

No results posted yet for this study

Summary

This study aims to assess the effectiveness of multichannel transcranial direct current stimulation (tDCS) in alleviating pain and to evaluate its safety in patients with central post-stroke pain (CPSP)

Conditions

Interventions

DEVICE

HD-tDCS

The HD-tDCS stimulation was applied for 20 minutes, 5 times a week, for a total of 10 sessions.

DEVICE

Sham High-Definition Transcranial Direct Current Stimulation(sham HD-tDCS)

The Sham HD-tDCS stimulation was applied for 20 minutes, 5 times a week, for a total of 10 sessions.

Sponsors & Collaborators

  • Pusan National University Yangsan Hospital

    lead OTHER

Principal Investigators

  • Young-Il Shin, Dr. · Pusan National University Yangsan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-24
Primary Completion
2024-04-24
Completion
2025-07-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06740591 on ClinicalTrials.gov